Neuphoria Therapeutics Inc.

NEUPNASDAQ Global Market·USD·Closed

NEUPNASDAQ·USD·Closed

$3.88

−1.02%

$3.88

−$0.04 (1.02%)

52W Range

4thpctl

Volume

0.19×avg

Mkt Cap

20.97MUSD

P/E

-0.4TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

4thpctl

Volume

0.19×avg

Market Cap

20.97MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+0.0% / yr

Operating margin230.7%

ROIC-72.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio14.31×